Theriva Biologics Inc Com Par $.001 Gains 36.3%
Fri, Nov 01, 2024 at 07:35 PM
Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT) shot up at $1.99, a gain of 36.3%. On Fri, Nov 01, 2024, TOVX:NYSEMKT hit a New 2-Week High of $1.99. The stock got featured on our News Catalysts scanner on Thu, Oct 31, 2024 at 07:36 PM in the 'BIOTECH' category. From Fri, Oct 18, 2024, the stock recorded 50.00% Up Days and 27.27% Green Days
The stock spiked on Fri, Nov 01, 2024 at $2.64 with a volume of 85M+.
About Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT)
Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics.
Top 10 Gainers:
- Vast Renewables Limited (VSTE:NASDAQ), 140%
- ChromaDex Corporation (CDXC:NASDAQ), 67.91%
- Athira Pharma Inc. (ATHA:NASDAQ), 41.53%
- Proto Labs, Inc. (PRLB:NYSE), 38.69%
- Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 36.3%
- Interface, Inc. (TILE:NASDAQ), 33.03%
- Globalstar, Inc. (GSAT:NYSEMKT), 31.43%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 27.71%
- Nexalin Technology Inc. (NXL:NASDAQ), 26.91%
- GRI Bio Inc Com (GRI:NASDAQ), 25.28%